ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2986

The Impact of Exercise and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study

Nancy A. Shadick1, Christine K Iannaccone2, Patricia Katz3, Gabriela L. Maica4, Jonathan Coblyn5, Michael E Weinblatt6 and Jing Cui7, 1Rheumatology Immunology & Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Brigham and Women’s Hospital, Boston, MA, 3University of California San Francisco, San Francisco, CA, 4Department of Rheumatology, Allergy, and Immunology, Brigham and Women's Hospital, Boston, MA, 5Department of Rheumatology, Brigham & Womens Hospital, Boston, MA, 6Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 7Division of Medicine and Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cognitive dysfunction, Disease Activity, drug therapy, exercise and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, October 24, 2018

Title: 6W023 ACR Abstract: RA–DX, Manifestations, & Outcomes VI: Outcomes Reports (2982–2987)

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Modifiable lifestyle factors such as inactivity and obesity contribute to cognitive decline in the general population, but little is known about how these factors may contribute in the setting of a chronic inflammatory condition such as Rheumatoid Arthritis (RA). We studied the clinical and functional risk factors related to a decrease in perceived cognition function in patients with longstanding RA.

Methods: We collected data on joint exams, serologies and detailed clinical, psychological, exercise and functional outcomes over 10 years in a prospective academic RA cohort. Self-reported memory, concentration and word-finding difficulties were assessed yearly by questionnaire and graded from “never” to “often”. A repeated measures logistic regression model using pairs of years examined the role of exercise (defined as those meeting the Dept. of HHS physical activity guidelines of 75 minutes of vigorous or 115 minutes of moderate aerobic activity per week), Body Mass Index (BMI), sleep and depression (MHI-5) in the first year (T0) to the progression of cognitive complaints described as “often” 1 year later (T1). Regression models also adjusted for other clinical and demographic variables including DAS-CRP3 score, DMARD and corticosteroid use.

Results: Of 1219 RA subjects, 127 (10.4%) described either poor memory, poor concentration or word finding difficulties as affecting them “often” at the first study visit. Only the perception of memory difficulties increased over time (R2=0.64, test for trend, p=0.006). RA patients, (mean age. 56.5 years, 82% female, 58% with a college education) were less likely to develop word finding difficulties and impaired concentration if they met the Dept. of HHS physical activity recommendations (p<0.0001; p=0.0002, respectively). Concentration worsened among those RA patients who were female (p=0.03), had a higher DAS28-CRP3 score (p=0.04), and higher MHI-5 depression scores (p=0.05); RA patients taking an anti-TNF therapy were less likely to develop worsened memory complaints (p=0.0004). Sleep, BMI, fatigue and medication use, such as methotrexate or corticosteroids, were not independently associated with a worsening of any of the cognitive complaints, adjusting for other covariates.

Conclusion: Clinical factors such as lower disease activity and anti-TNF use reduced the likelihood of worsened memory and concentration over time. However, meeting the Dept. of HHS guidelines for physical activity was protective against an increase in concentration and word retrieval difficulties. Our study suggests potential modifiable risk factors for the prevention of cognitive dysfunction in RA.


Disclosure: N. A. Shadick, Amgen, Mallinckrodt, Bristol-Myers Squibb, Sanofi-Regeneron, 2,Bristol-Myers Squibb, 5; C. K. Iannaccone, None; P. Katz, Bristol-Myers Squibb, 2; G. L. Maica, None; J. Coblyn, None; M. E. Weinblatt, Amgen, BMS, Crescendo Bioscience, Sanofi/Regeneron, 2,Abbvie, Amgen, BMS, Crescendo Bioscience, Corrono, GSK, Gilead, Eli Lilly and Company, Lycera, Merck, Novartis, Pfizer, Roche, Samsung, Set Point, UCB, 5,Lycero, Can-fite, Scipher, Vorso, Inmedix, 1; J. Cui, None.

To cite this abstract in AMA style:

Shadick NA, Iannaccone CK, Katz P, Maica GL, Coblyn J, Weinblatt ME, Cui J. The Impact of Exercise and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-impact-of-exercise-and-clinical-factors-on-perceived-cognitive-function-in-patients-with-rheumatoid-arthritis-results-from-a-prospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-exercise-and-clinical-factors-on-perceived-cognitive-function-in-patients-with-rheumatoid-arthritis-results-from-a-prospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology